학술논문
A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer.
Document Type
Journal Article
Author
Source
Subject
*NON-small-cell lung carcinoma
*CANCER treatment
*DNA repair
*RIBONUCLEOSIDE diphosphate reductase
*MESSENGER RNA
*DOCETAXEL
*CARBOPLATIN
*CANCER chemotherapy
*GENE expression
*RNA metabolism
*ANTINEOPLASTIC agents
*CLINICAL trials
*COMPARATIVE studies
*ESTERASES
*GENES
*HYDROCARBONS
*LUNG cancer
*LUNG tumors
*RESEARCH methodology
*MEDICAL cooperation
*PROGNOSIS
*PROTEINS
*RESEARCH
*SURVIVAL
*VINBLASTINE
*DNA-binding proteins
*EVALUATION research
*RANDOMIZED controlled trials
*TREATMENT effectiveness
*DEOXYCYTIDINE
*PHARMACODYNAMICS
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0344-5704
Abstract